GENMAB A/S - 12 Dec 2025 SCHEDULE 13D Report for Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS)

Filing Manager
GENMAB A/S
Reporting Manager
Genmab A/S
Security
Merus N.V. Common Shares, Euro 0.09 nominal value per share
Symbol
MRUS
Shares outstanding
75,893,250 shares
Disclosed Ownership
71,946,801 shares
Ownership
95%
Form type
SCHEDULE 13D
Filing time
19 Dec 2025, 12:32:00 UTC
Date of event
12 Dec 2025
Next filing
30 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Genmab A/S 95% 71,946,801 0 71,946,801 /s/ Jan G. J. van de Winkel Jan G. J. van de Winkel, President & Chief Executive Officer 0001434265
Genmab Holding II B.V. 95% 71,946,801 0 71,946,801 /s/ Jan G. J. van de Winkel Jan G. J. van de Winkel, Authorized Signatory